Furthermore, Orai1 is overexpressed in gastric cancer, colorectal cancer and oral cancer, and has been associated with increased migration and invasiveness in breast cancer, colon cancer, gastric cancer and esophageal cancer. Here, ORAI1 is linked to esophageal cancer.